|
COPYRIGHT 2007 International Medical News Group
MAUI, HAWAII -- Etanercept might be the clear market leader among the biologic therapies for psoriasis, but infliximab rules the roost in terms of efficacy, according to Dr. Craig L. Leonardi.
"Infliximab gets the highest steady state concentration in the body of all the biologics. Frankly, this one gets the job done when all the others have fallen short," he said at the annual Hawaii Dermatology Seminar sponsored by Skin Disease Education Foundation.
The biggest barrier to more widespread use of infliximab (Remicade) by dermatologists is the need for an office infusion center, but increasing numbers of dermatologists are realizing...
Read the full article for free courtesy of your local library.
| 
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
